Evidence map›Paper›PMID 26386038›Full record

ReviewJournal of immunology (Baltimore, Md. : 1950)2015

Translating the Untranslated Region.

Johannes Schwerk, Ram Savan

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Review
  3. Exosomes and Exosome-Mimetics for Atopic Dermatitis Therapy.Tissue engineering and regenerative medicine · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Sour Taste SNPFrontiers in nutrition · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Johannes SchwerkDepartment of Immunology, University of Washington, Seattle, WA 98109.
Ram SavanDepartment of Immunology, University of Washington, Seattle, WA 98109 savanram@uw.edu.
University of Washington · US

Funding

Novel regulatory mechanisms control IFNL3 expression during HCV infectionR01AI108765 · NIAID · UNIVERSITY OF WASHINGTON · PI SAVAN, RAM · 2014 to 2018
$2.3M
NIAID NIH HHS 1R01AI108765NIAID NIH HHS R01 AI108765
6 · The paper itself

Abstract

Gene expression programs undergo constant regulation to quickly adjust to environmental stimuli that alter the physiological status of the cell, like cellular stress or infection. Gene expression is tightly regulated by multilayered regulatory elements acting in both cis and trans. Posttranscriptional regulation of the 3' untranslated region (UTR) is a powerful regulatory process that determines the rate of protein translation from mRNA. Regulatory elements targeting the 3' UTR include microRNAs, RNA-binding proteins, and long noncoding RNAs, which dramatically alter the immune response. We provide an overview of our current understanding of posttranscriptional regulation of immune gene expression. The focus of this review is on regulatory elements that target the 3' UTR. We delineate how the synergistic or antagonistic interactions of posttranscriptional regulators determine gene expression levels and how dysregulation of 3' UTR-mediated posttranscriptional control associates with human diseases.

Indexed as

3' Untranslated RegionsGene Expression RegulationHumansMicroRNAsPolyadenylationRegulatory Sequences, Nucleic AcidRNA-Binding ProteinsRNA, Long NoncodingRNA, MessengerRNA Processing, Post-Transcriptional3' Untranslated RegionsMicroRNAsRNA-Binding ProteinsRNA, Long NoncodingRNA, Messenger

Identifiers

PMID26386038
PMCPMC4648541
OpenAlexW2253875649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.